HistoRx is a biotech company developing personalized medicine to improve individualized patient care.
HistoRx is developing theranostic solutions to towards individualized patient care. HistoRx's proprietary technology delivers objective and reproducible multiparametric analysis of proteins in tissue, providing insights into cancer treatment.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 27, 2011 | Series Unknown | $2.60M | 1 | — | — | Detail |
Oct 24, 2007 | Series B | $6M | 1 | — | — | Detail |
Sep 14, 2004 | Series A | $1.50M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Commons Capital | — | Series Unknown |
Sachem Ventures | — | Series A |